The FDA-approved criteria require a BMI of 30 or greater (obesity), or a BMI of 27 or greater with at least one weight-related comorbidity such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease
Knowing the management strategies prevents unnecessary medication discontinuation
Glucagon-like peptide-1 modulates RAW264.7 macrophage polarization by interfering with the JNK/STAT3 signaling pathway
GLP-1 medications work by overriding the body natural weight regulation system, which is powerful and persistent
If so, what are the criteria for approval
Severe GERD may present with respiratory symptoms including chronic cough, throat clearing, and a sensation of breathlessness, particularly when lying down